QQQ   267.51 (+0.39%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
QQQ   267.51 (+0.39%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
QQQ   267.51 (+0.39%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
QQQ   267.51 (+0.39%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
Log in
NYSE:LLY

Eli Lilly And Co Stock Forecast, Price & News

$151.18
-2.99 (-1.94 %)
(As of 09/21/2020 12:00 AM ET)
Add
Compare
Today's Range
$149.06
Now: $151.18
$153.66
50-Day Range
$146.22
MA: $150.64
$154.85
52-Week Range
$101.36
Now: $151.18
$170.75
Volume3.38 million shs
Average Volume3.92 million shs
Market Capitalization$144.60 billion
P/E Ratio24.54
Dividend Yield1.92%
Beta0.18
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates in two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions. The company also provides neuroscience products for the treatment of depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorder; obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains, as well as migraine prevention. In addition, it offers immunology products for the treatment of rheumatoid arthritis and plaque psoriasis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia, and acute coronary syndrome. Further, the company provides animal health products, such as cattle feed additives; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and enteric diseases in swine and poultry; anticoccidial agents for poultry use; and chewable tablets that kill fleas and prevent heartworm diseases. Additionally, it offers vaccines to prevent bordetella, Lyme disease, rabies, and parvovirus. The company has collaboration agreements with Daiichi Sankyo Co., Ltd.; Incyte Corporation; Pfizer Inc.; AstraZeneca; Nektar Therapeutics; NextCure, Inc.; Dicerna Pharmaceuticals; AC Immune SA; and Avidity Biosciences, Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Read More
Eli Lilly And Co logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 2.7Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.97 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP53245710
Phone317-276-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$22.32 billion
Cash Flow$7.19 per share
Book Value$2.81 per share

Profitability

Net Income$8.32 billion

Miscellaneous

Employees33,625
Market Cap$144.60 billion
Next Earnings Date10/28/2020 (Estimated)
OptionableOptionable
$151.18
-2.99 (-1.94 %)
(As of 09/21/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LLY News and Ratings via Email

Sign-up to receive the latest news and ratings for LLY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Eli Lilly And Co (NYSE:LLY) Frequently Asked Questions

How has Eli Lilly And Co's stock price been impacted by Coronavirus (COVID-19)?

Eli Lilly And Co's stock was trading at $140.02 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, LLY shares have increased by 8.0% and is now trading at $151.18.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Eli Lilly And Co?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eli Lilly And Co in the last year. There are currently 3 hold ratings, 8 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Eli Lilly And Co
.

When is Eli Lilly And Co's next earnings date?

Eli Lilly And Co is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for Eli Lilly And Co
.

How were Eli Lilly And Co's earnings last quarter?

Eli Lilly And Co (NYSE:LLY) released its quarterly earnings data on Thursday, July, 30th. The company reported $1.89 EPS for the quarter, topping analysts' consensus estimates of $1.58 by $0.31. The business had revenue of $5.50 billion for the quarter, compared to the consensus estimate of $5.77 billion. Eli Lilly And Co had a net margin of 24.48% and a return on equity of 183.80%. Eli Lilly And Co's quarterly revenue was down 2.4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.50 earnings per share.
View Eli Lilly And Co's earnings history
.

How often does Eli Lilly And Co pay dividends? What is the dividend yield for Eli Lilly And Co?

Eli Lilly And Co announced a quarterly dividend on Wednesday, July 15th. Investors of record on Friday, August 14th will be paid a dividend of $0.74 per share on Thursday, September 10th. This represents a $2.96 annualized dividend and a dividend yield of 1.96%. The ex-dividend date of this dividend is Thursday, August 13th.
View Eli Lilly And Co's dividend history
.

What guidance has Eli Lilly And Co issued on next quarter's earnings?

Eli Lilly And Co updated its FY20 earnings guidance on Thursday, July, 30th. The company provided EPS guidance of $7.20-$7.40 for the period, compared to the Thomson Reuters consensus estimate of $6.84. The company issued revenue guidance of $23.7-$24.2 billion, compared to the consensus revenue estimate of $23.94 billion.

What price target have analysts set for LLY?

12 Wall Street analysts have issued 1 year price objectives for Eli Lilly And Co's shares. Their forecasts range from $158.00 to $190.00. On average, they expect Eli Lilly And Co's stock price to reach $172.27 in the next year. This suggests a possible upside of 14.0% from the stock's current price.
View analysts' price targets for Eli Lilly And Co
.

Are investors shorting Eli Lilly And Co?

Eli Lilly And Co saw a increase in short interest in August. As of August 31st, there was short interest totaling 4,660,000 shares, an increase of 9.6% from the August 15th total of 4,250,000 shares. Based on an average daily volume of 3,200,000 shares, the days-to-cover ratio is presently 1.5 days. Currently, 0.6% of the shares of the stock are sold short.
View Eli Lilly And Co's Short Interest
.

Who are some of Eli Lilly And Co's key competitors?

What other stocks do shareholders of Eli Lilly And Co own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Eli Lilly And Co investors own include Johnson & Johnson (JNJ), Pfizer (PFE), NVIDIA (NVDA), Intel (INTC), Cisco Systems (CSCO), Bristol-Myers Squibb (BMY), Merck & Co., Inc. (MRK), AT&T (T), Walt Disney (DIS) and AbbVie (ABBV).

Who are Eli Lilly And Co's key executives?

Eli Lilly And Co's management team includes the following people:
  • Mr. David A. Ricks, Chairman, CEO & Pres (Age 51)
  • Mr. Joshua L. Smiley, Sr. VP & CFO (Age 49)
  • Dr. Daniel M. Skovronsky, Sr. VP & Chief Scientific Officer (Age 45)
  • Mr. Michael J. Harrington, Sr. VP & Gen. Counsel (Age 56)
  • Mr. Jeffrey N. Simmons, Sr. VP & Pres of Elanco Animal Health (Age 52)

What is Eli Lilly And Co's stock symbol?

Eli Lilly And Co trades on the New York Stock Exchange (NYSE) under the ticker symbol "LLY."

Who are Eli Lilly And Co's major shareholders?

Eli Lilly And Co's stock is owned by a variety of institutional and retail investors. Top institutional investors include Lilly Endowment Inc. (11.66%), Vanguard Group Inc. (7.49%), BlackRock Inc. (6.57%), FMR LLC (3.14%), Bank of New York Mellon Corp (0.95%) and Jennison Associates LLC (0.84%). Company insiders that own Eli Lilly And Co stock include Aarti S Shah, Alfonso G Zulueta, Anne E White, Christi Shaw, David A Ricks, Donald A Zakrowski, Eli & Co Lilly, Enrique A Conterno, Jackson P Tai, Joshua L Smiley, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill and Stephen F Fry.
View institutional ownership trends for Eli Lilly And Co
.

Which institutional investors are selling Eli Lilly And Co stock?

LLY stock was sold by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Lilly Endowment Inc., BlackRock Inc., Vanguard Group Inc., Toronto Dominion Bank, Advisor Group Holdings Inc., Bank of Montreal Can, and AJO LP. Company insiders that have sold Eli Lilly And Co company stock in the last year include Aarti S Shah, Alfonso G Zulueta, Lilly Endowment Inc, Melissa S Barnes, Myles O'neill, and Stephen F Fry.
View insider buying and selling activity for Eli Lilly And Co
.

Which institutional investors are buying Eli Lilly And Co stock?

LLY stock was acquired by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, FMR LLC, Nordea Investment Management AB, Two Sigma Advisers LP, Robeco Institutional Asset Management B.V., Prudential Financial Inc., Winslow Capital Management LLC, and Bank of New York Mellon Corp. Company insiders that have bought Eli Lilly And Co stock in the last two years include Anne E White, David A Ricks, Jackson P Tai, and Joshua L Smiley.
View insider buying and selling activity for Eli Lilly And Co
.

How do I buy shares of Eli Lilly And Co?

Shares of LLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Eli Lilly And Co's stock price today?

One share of LLY stock can currently be purchased for approximately $151.18.

How big of a company is Eli Lilly And Co?

Eli Lilly And Co has a market capitalization of $144.60 billion and generates $22.32 billion in revenue each year. The company earns $8.32 billion in net income (profit) each year or $6.04 on an earnings per share basis. Eli Lilly And Co employs 33,625 workers across the globe.

What is Eli Lilly And Co's official website?

The official website for Eli Lilly And Co is www.lilly.com.

How can I contact Eli Lilly And Co?

Eli Lilly And Co's mailing address is LILLY CORPORATE CENTER, INDIANAPOLIS IN, 46285. The company can be reached via phone at 317-276-2000 or via email at [email protected]

This page was last updated on 9/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.